CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
4.990
+0.850 (20.53%)
Sep 20, 2024, 4:00 PM EDT - Market closed
CalciMedica Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 8.79 | 9.52 | 5.84 | 5.06 | 4.85 |
| Research & Development | 12.66 | 12.36 | 8.35 | 16.48 | 9.65 |
| Operating Expenses | 21.45 | 21.88 | 14.19 | 21.54 | 14.5 |
| Operating Income | -21.45 | -21.88 | -14.19 | -21.54 | -14.5 |
| Interest Expense | - | -0.11 | -0.13 | - | -0.04 |
| Interest & Investment Income | 1 | 0.7 | - | - | - |
| Other Non Operating Income (Expenses) | 5.84 | 1.11 | 3.76 | -1.96 | 0.32 |
| EBT Excluding Unusual Items | -14.61 | -20.18 | -10.57 | -23.5 | -14.22 |
| Merger & Restructuring Charges | - | -16.2 | - | - | - |
| Other Unusual Items | 2.02 | 2.02 | 2.75 | - | -0.96 |
| Pretax Income | -12.59 | -34.36 | -7.82 | -23.5 | -15.18 |
| Net Income | -12.59 | -34.36 | -7.82 | -23.5 | -15.18 |
| Preferred Dividends & Other Adjustments | - | - | 1.32 | - | - |
| Net Income to Common | -12.59 | -34.36 | -9.14 | -23.5 | -15.18 |
| Shares Outstanding (Basic) | 8 | 4 | 0 | 3 | 3 |
| Shares Outstanding (Diluted) | 8 | 4 | 0 | 3 | 3 |
| Shares Change (YoY) | 383.85% | 5354.75% | -96.97% | 3.08% | - |
| EPS (Basic) | -1.56 | -7.66 | -111.16 | -8.65 | -5.76 |
| EPS (Diluted) | -1.56 | -7.66 | -111.16 | -8.65 | -5.76 |
| Free Cash Flow | -19.69 | -25.81 | -11.76 | -20.72 | -9.85 |
| Free Cash Flow Per Share | -2.44 | -5.75 | -143.00 | -7.63 | -3.74 |
| EBITDA | -21.39 | -21.82 | -14.14 | -21.5 | -14.5 |
| D&A For EBITDA | 0.06 | 0.06 | 0.05 | 0.04 | 0.01 |
| EBIT | -21.45 | -21.88 | -14.19 | -21.54 | -14.5 |
Source: S&P Capital IQ. Standard template.
Financial Sources.